Cargando…

Adoptive cell therapy with CD4(+) T helper 1 cells and CD8(+) cytotoxic T cells enhances complete rejection of an established tumour, leading to generation of endogenous memory responses to non-targeted tumour epitopes

The results of adoptive T-cell therapies (ACTs) are very encouraging and show clinical evidence that ACT can provide a cure for patients with metastatic disease. However, various response rates and long-term cancer remission have been observed in different ACT trials. The types of T cells, prior tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Kunyu, Donaldson, Braeden, Young, Vivienne, Ward, Vernon, Jackson, Christopher, Baird, Margaret, Young, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671987/ https://www.ncbi.nlm.nih.gov/pubmed/29114389 http://dx.doi.org/10.1038/cti.2017.37

Ejemplares similares

Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.
por: Nakamura, Y., et al.
Publicado: (1992)

Delivering Two Tumour Antigens Survivin and Mucin-1 on Virus-Like Particles Enhances Anti-Tumour Immune Responses
por: Campbell, Katrin, et al.
Publicado: (2021)

Adoptive tumour immunotherapy using human CD4+ T-cells.
por: Gold, J. E., et al.
Publicado: (1993)

Combining dendritic cells and B cells for presentation of oxidised tumour antigens to CD8(+) T cells
por: Grant, Melanie L, et al.
Publicado: (2017)

Synergy between CD8 T Cells and Th1 or Th2 Polarised CD4 T Cells for Adoptive Immunotherapy of Brain Tumours
por: Hoepner, Sabine, et al.
Publicado: (2013)

Conditions for the generation of cytotoxic CD4(+) Th cells that enhance CD8(+) CTL-mediated tumor regression
por: Li, Kunyu, et al.
Publicado: (2016)

CD8+ T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope
Publicado: (1992)

Helper cell-independent antitumor activity of potent CD8(+) T cell epitope peptide vaccines is dependent upon CD40L
por: Llopiz, Diana, et al.
Publicado: (2013)

Efficient Presentation of Multiple Endogenous Epitopes to Both CD4(+) and CD8(+) Diabetogenic T Cells for Tolerance
por: Dastagir, Shamael R., et al.
Publicado: (2016)

Tumour rejection in rats sensitized to embryonic tissue. I. Rejection of tumour cells implanted s.c. and detection of cytotoxic lymphoid cells.
por: Shah, L. P., et al.
Publicado: (1976)

Nanoparticle-based modulation of CD4(+) T cell effector and helper functions enhances adoptive immunotherapy
por: Isser, Ariel, et al.
Publicado: (2022)

Co-Ordination of Mucosal B Cell and CD8 T Cell Memory by Tissue-Resident CD4 Helper T Cells
por: Son, Young Min, et al.
Publicado: (2021)

An Enhanced Heterologous Virus-Like Particle for Human Papillomavirus Type 16 Tumour Immunotherapy
por: Jemon, Khairunadwa, et al.
Publicado: (2013)

Magnetic targeting of adoptively transferred tumour-specific nanoparticle-loaded CD8(+) T cells does not improve their tumour infiltration in a mouse model of cancer but promotes the retention of these cells in tumour-draining lymph nodes
por: Sanz-Ortega, Laura, et al.
Publicado: (2019)

Identification of novel helper epitopes of MAGE-A4 tumour antigen: useful tool for the propagation of Th1 cells
por: Ohkuri, T, et al.
Publicado: (2009)

Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection
por: Alsughayyir, Jawaher, et al.
Publicado: (2019)

Virus-Like Particles, a Versatile Subunit Vaccine Platform
por: Donaldson, Braeden, et al.
Publicado: (2014)

The Roles of CD8(+) and CD4(+) Cells in Tumor Rejection
por: Udono, Heiichiro, et al.
Publicado: (1989)

DNA alterations in Cd133+ and Cd133- tumour cells enriched from intra-operative human colon tumour biopsies
por: Cervantes-Madrid, Diana, et al.
Publicado: (2017)

Complementary Dendritic Cell–activating Function of CD8(+) and CD4(+) T Cells: Helper Role of CD8(+) T Cells in the Development of T Helper Type 1 Responses
por: Mailliard, Robbie B., et al.
Publicado: (2002)

Memory T Follicular Helper CD4 T Cells
por: Hale, J. Scott, et al.
Publicado: (2015)

CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma
por: Hoe, Susan Ling Ling, et al.
Publicado: (2017)

Tumour stem cell markers CD133 and CD44 are useful prognostic factors after surgical resection of pancreatic neuroendocrine tumours
por: Sun, Zhonghai, et al.
Publicado: (2020)

CD4(+) and CD8(+) T Cells Can Act Separately in Tumour Rejection after Immunization with Murine Pneumotropic Virus Chimeric Her2/neu Virus-Like Particles
por: Andreasson, Kalle, et al.
Publicado: (2010)

Promises and challenges of adoptive T-cell therapies for solid tumours
por: Morotti, Matteo, et al.
Publicado: (2021)

Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8(+) T cell epitopes
por: Tellam, Judy, et al.
Publicado: (2007)

Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
por: Symonds, Alistair L. J., et al.
Publicado: (2022)

Small round tumour cells (CD38, CD 79a positive) in the adrenal gland
por: Nigam, L.A., et al.
Publicado: (2017)

B Cells Negatively Regulate the Establishment of CD49b(+)T-bet(+) Resting Memory T Helper Cells in the Bone Marrow
por: Hojyo, Shintaro, et al.
Publicado: (2016)

Establishing Molecular Subgroups of CD8+ T Cell-Associated Genes in the Ovarian Cancer Tumour Microenvironment and Predicting the Immunotherapy Response
por: Zhu, Yunshu, et al.
Publicado: (2023)

LXR-Mediated Inhibition of CD4(+) T Helper Cells
por: Solt, Laura A., et al.
Publicado: (2012)

Editorial: CD4 T Follicular Helper Cells in HIV
por: Iyer, Smita S.
Publicado: (2017)

Immunohistochemical Assessment of the Tumour-Associated Epitopes CD44v6 and E48 in Tumour-Free Lymph Nodes from Patients with Squamous Cell Carcinoma in the Head-Neck Region
por: Fabricius, Eva-Maria, et al.
Publicado: (2000)

CD133 induces tumour-initiating properties in HEK293 cells
por: Canis, Martin, et al.
Publicado: (2012)

Absence of Grail promotes CD8(+) T cell anti-tumour activity
por: Haymaker, Cara, et al.
Publicado: (2017)

The role of CD4 T cells in rejection of solid tumors
por: Poncette, Lucia, et al.
Publicado: (2022)

The distinct role of CD4(+) and CD8(+) T-cells during the anti-tumour effects of targeted superantigens
por: Litton, M J, et al.
Publicado: (1999)

PD-L1 expression patterns in tumour cells and their association with CD8(+) tumour infiltrating lymphocytes in clear cell renal cell carcinoma
por: Zhu, Qian, et al.
Publicado: (2019)

CD49b/CD69-Dependent Generation of Resting T Helper Cell Memory
por: Hanazawa, Asami, et al.
Publicado: (2013)

Endogenous Interleukin 4 Is Required for Development of Protective CD4(+) T Helper Type 1 Cell Responses to Candida albicans
por: Mencacci, Antonella, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_0923i8m0jjc4r14n5c3ad55gq5